Development of potent and proteolytically stable human neuromedin U receptor agonists

De Prins, A. and Martin, C. B. and Van Wanseele, Y and Skov, L. J. and Tömböly, Csaba (2018) Development of potent and proteolytically stable human neuromedin U receptor agonists. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 144. pp. 887-897. ISSN 0223-5234


Download (2MB) | Preview


Neuromedin U (NMU) is a highly conserved endogenous peptide that is involved in a wide range of physiological processes such as regulation of feeding behavior, the stress response and nociception. The major limitation to use NMU as a therapeutic is its short half-life. Here, we describe the development of a set of novel NMU-analogs based on NMU-8, by introducing unnatural amino acids into the native sequence. This approach shows that it is possible to generate molecules with increased potency and improved plasma stability without major changes of the peptidic nature or the introduction of large conjugates. When compared to the native NMU-8 peptide, compounds 16,18 and 20 have potent agonist activity and affinity for both NMU receptors. Selectivity towards NMUR1 was observed when the Phe residue in position 4 was modified, whereas higher potencies at NMUR2 were found when substitutions of the Pro residue in position 6 were executed. To study the effect of the modifications on the proteolytic stability of the molecules, an in vitro stability assay in human plasma at 37 degrees C was performed. All analyzed analogs possessed an increased resistance against enzymatic degradation in human plasma resulting in half-lifes from 4 min for NMU-8, up to more than 23 h for compound 42. (C) 2017 Elsevier Masson SAS. All rights reserved.

Item Type: Article
Subjects: Q Science / természettudomány > QH Natural history / természetrajz > QH301 Biology / biológia > QH3011 Biochemistry / biokémia
Depositing User: MTMT SWORD
Date Deposited: 30 Jan 2019 13:58
Last Modified: 30 Jan 2019 13:58

Actions (login required)

Edit Item Edit Item